GCM
WVE icon

Graham Capital Management’s Wave Life Sciences WVE Stock Holding History

Graham Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,946
Closed -$322K – 1621
2025
Q3 		$322K Buy
+43,946
New +$356K 0.01% 827
2024
Q4 		– Sell
-20,950
Closed -$172K – 1510
2024
Q3 		$172K Buy
+20,950
New +$125K ﹤0.01% 949
2024
Q2 		– Sell
-34,199
Closed -$211K – 1409
2024
Q1 		$211K Buy
34,199
+16,907
+98% +$84.7K ﹤0.01% 883
2023
Q4 		$87.3K Buy
+17,292
New +$92.4K ﹤0.01% 914

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Graham Capital Management's WVE Position: Q4 2025 in Review

Graham Capital Management sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 43,946 shares — an estimated $322K sold.

Graham Capital Management first reported a position in WVE in Q4 2023 and held it in 4 quarters. The position peaked at $322K in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Graham Capital Management reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 43,946 Wave Life Sciences shares in Q4 2025, an estimated $322K.
  • Graham Capital Management first reported a position in Wave Life Sciences in Q4 2023 and held it in 4 quarters.
  • Graham Capital Management's Wave Life Sciences position peaked at $322K in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.